Manyu Gong
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Establishment of an induced pluripotent stem cell line (HMUCPi001-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3 c.3072C > A mutation.
Journal: Stem cell research
Published: March 21, 2025
The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 18, 2025
In situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMs.
Journal: Bioactive materials
Published: January 16, 2025
Palmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosis.
Journal: Acta pharmaceutica Sinica. B
Published: July 03, 2024
β-Hydroxybutyrate Facilitates Homeostasis of Hypoxic Endothelial Cells After Myocardial Infarction via Histone Lysine β-Hydroxybutyrylation of CPT1A.
Journal: JACC. Basic to translational science
Published: July 01, 2024
GDF11 mitigates high glucose-induced cardiomyocytes apoptosis by inhibiting the ALKBH5-FOXO3-CDR1as/Hippo signaling pathway.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: August 07, 2023
NAD+ attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages.
Journal: Vascular pharmacology
Published: June 03, 2022
CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy.
Journal: European journal of pharmacology
Published: November 04, 2021
LncRNA-ZFAS1 Promotes Myocardial Ischemia-Reperfusion Injury Through DNA Methylation-Mediated Notch1 Down-Regulation in Mice.
Journal: JACC. Basic to translational science
Published: November 01, 2021
Last Updated: 09/26/2026